Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0036 | 0.1766 | 0.1649 |
Schistosoma mansoni | tar DNA-binding protein | 0.0127 | 0.8435 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0127 | 0.8435 | 0.8435 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1766 | 0.1639 |
Mycobacterium leprae | conserved hypothetical protein | 0.0023 | 0.0794 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 0.1056 | 0.0748 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0794 | 0.2558 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0127 | 0.8435 | 0.8435 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.1766 | 0.1737 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0459 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0127 | 0.8435 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0149 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1766 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.1766 | 0.1639 |
Echinococcus granulosus | muscleblind protein | 0.0149 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.1056 | 0.1056 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0794 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 0.1056 | 0.1023 |
Echinococcus multilocularis | lamin | 0.0027 | 0.1056 | 0.1023 |
Echinococcus granulosus | tar DNA binding protein | 0.0127 | 0.8435 | 0.8429 |
Echinococcus granulosus | lamin | 0.0027 | 0.1056 | 0.1023 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0794 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.102 | 0.102 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0459 | 0.0425 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1766 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1056 | 0.1056 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 1 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0023 | 0.0794 | 0.5 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0023 | 0.0794 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0127 | 0.8435 | 0.8435 |
Echinococcus multilocularis | muscleblind protein | 0.0149 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.516 | 0.516 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0794 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.1056 | 0.1056 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0459 |
Brugia malayi | RNA binding protein | 0.0127 | 0.8435 | 0.8413 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0794 | 1 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0023 | 0.0794 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.1766 | 0.1737 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0127 | 0.8435 | 0.8413 |
Brugia malayi | intermediate filament protein | 0.0027 | 0.1056 | 0.0928 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0459 | 0.0323 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0794 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0459 | 0.5 |
Echinococcus multilocularis | musashi | 0.0027 | 0.1056 | 0.1023 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 0.1056 | 0.1023 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0083 | 0.516 | 0.5894 |
Brugia malayi | TAR-binding protein | 0.0127 | 0.8435 | 0.8413 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 1 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0083 | 0.516 | 0.5143 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1766 | 1 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0023 | 0.0794 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0459 | 0.0425 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0794 | 1 |
Schistosoma mansoni | lamin | 0.0027 | 0.1056 | 0.0748 |
Schistosoma mansoni | tar DNA-binding protein | 0.0127 | 0.8435 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 0.1056 | 0.1023 |
Echinococcus multilocularis | tar DNA binding protein | 0.0127 | 0.8435 | 0.8429 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0036 | 0.0036 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.1056 | 0.0928 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0083 | 0.516 | 0.5143 |
Onchocerca volvulus | 0.0083 | 0.516 | 1 | |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0023 | 0.0794 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1766 | 1 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0083 | 0.516 | 0.5091 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0459 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0127 | 0.8435 | 1 |
Schistosoma mansoni | lamin | 0.0027 | 0.1056 | 0.0748 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0141 | 0.0141 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0023 | 0.0794 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0127 | 0.8435 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.